AU Patent

AU2003234285B2 — Formulations containing amiodarone and sulfoalkyl ether cyclodextrin

Assigned to Cydex Pharmaceuticals Inc · Expires 2007-01-04 · 19y expired

What this patent protects

The invention relates to a clear liquid formulation comprising amiodarone, a method of preparing said formulation and its use for the treatment of cardiac disorders.

USPTO Abstract

The invention relates to a clear liquid formulation comprising amiodarone, a method of preparing said formulation and its use for the treatment of cardiac disorders.

Drugs covered by this patent

Patent Metadata

Patent number: AU2003234285B2
Jurisdiction: AU
Classification: —
Expires: 2007-01-04
Drug substance claim: No
Drug product claim: No
Assignee: Cydex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.